Navigation Links
INVEGA® Approved as Treatment for Schizophrenia in Adolescents
Date:4/11/2011

rch & Development, L.L.C.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) is a subsidiary of Johnson & Johnson, the world's most broadly based producer of health care products. J&JPRD is headquartered in Raritan, N.J., and has facilities throughout the United States, Europe and Asia. J&JPRD is focusing its drug discovery and drug development efforts to address unmet medical needs worldwide in a variety of therapeutic areas including cardiovascular and metabolic diseases, oncology, immunology, central nervous system disorders, including pain, and virology. More information can be found at http://www.jnjpharmarnd.com.

About Janssen

Janssen Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., is based in Titusville, N.J., and is the only large pharmaceutical company in the U.S. dedicated solely to mental health. It currently markets prescription medications for the treatment of schizophrenia, bipolar mania, schizoaffective disorder and the treatment of symptoms associated with autistic disorder. Ortho-McNeil-Janssen Pharmaceuticals, Inc, is a member of the Johnson & Johnson family of companies. For more information about Janssen, visit http://www.janssen.com.

Media Contact:  
Greg Panico
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
609-730-3061 (office)

Investor Contacts:
Louise Mehrotra
Johnson & Johnson
732-524-6491

Stan Panasewicz
Johnson & Johnson
732-524-2524


'/>"/>
SOURCE Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Analysis of Longer-Term Clinical Study Suggests Psychiatric Hospitalization Rates Decreased in Adults with Schizophrenia Treated With INVEGA® SUSTENNA®
2. FDA CONSUMER HEALTH INFORMATION - FDA Intends to Remove Unapproved Drugs From Market
3. FDA Prompts Removal of Unapproved Drugs From Market
4. Roche Teams with Womack Army Medical Center to Become First IVD Manufacturer approved for Remote Network Connectivity with DOD
5. DURECT Announces Launch of First FDA Approved SABER™-Injectable Peptide Product
6. FDA: Gardasil Approved to Prevent Anal Cancer
7. CO-REC Unveils List of Approved Electronic Health Record Products
8. Bionovo Releases FDA-Approved Clinical Development Plan for Menerba
9. A Majority of Surveyed PCPs and Endocrinologists Indicate that they will Prescribe Contrave, Lorqess and Qnexa if these Therapies are Approved for Obesity
10. Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs
11. VIDEO from thenewsmarket.com and Novartis: Novartis drug Afinitor® Approved by FDA as First Medication for Children and Adults With a Benign Brain Tumor Associated With Tuberous Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Pa. , Sept. 2, 2015 ... increases, diversifies revenue base with highly profitable specialty ... , Near-term growth potential with 11 product ... include Paragraph IV certifications  , Provides medium ... candidates in development, including eight controlled substances ...
(Date:9/2/2015)... Sept. 2, 2015 Research and Markets ( ... "Inhaled Drug Delivery (London, UK - November 19-20, 2015)" ... Drug Delivery meeting will cover industry case studies, regulatory ... The Co-Chairmen are Dr Steven Nichols , OINP ... Mylan. Companies participating include: ...
(Date:9/2/2015)... , Sept. 2, 2015  Seeger Weiss LLP ... bellwether trial will commence October 13, 2015. ... the 510K fast-track approval program, Zimmer NexGen knee implant ... only requires that companies provide evidence that the product ... in order to gain permissions. In ...
Breaking Medicine Technology:Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 2Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 3Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 4Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 5Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 6Seeger Weiss LLP Reports That Zimmer NexGen Knee MDL Bellwether Trial Date Set For October 13, 2015 2
... 8 Novavax, Inc. (Nasdaq: NVAX ) ... Driscoll, Chief Financial Officer of Novavax will be presenting ... place on Friday, September 17, 2010 at 10:20am local ... Driscoll will provide a company overview, outline its competitive ...
... (Nasdaq: TRBN ) today announced that the ... early termination of the waiting period under the Hart-Scott-Rodino ... with respect to the planned acquisition of Trubion by ... on Aug. 12, 2010. Accordingly, the requirement under the ...
Cached Medicine Technology:Trubion Pharmaceuticals Announces Early Termination of HSR Waiting Period 2Trubion Pharmaceuticals Announces Early Termination of HSR Waiting Period 3Trubion Pharmaceuticals Announces Early Termination of HSR Waiting Period 4
(Date:9/3/2015)... ... 03, 2015 , ... James Earl Jones will be hosting an upcoming VOICES ... Earl Jones will introduce a segment that discusses why it is important for the ... can be fostered in any working environment. , Employers are out billions of dollars ...
(Date:9/3/2015)... ... September 03, 2015 , ... Fashion designer Kim (29 years old, Honolulu, ... recent episode of the hit ABC series “Extreme Weight Loss” Season 5 . ... industry. She provided herself with the motivation to transform when she designed a drop-dead-gorgeous ...
(Date:9/2/2015)... (PRWEB) , ... September 03, 2015 , ... ... at Johns Hopkins University Bloomberg School of Public Health and an internationally recognized ... House Fellows program for 2015-16. Dr. Bleich, a Baltimore native and 1996 graduate ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... cosponsored by the Military Officers Association of America (MOAA) and Wounded Warrior ... Military: Caring For Our Own,” expert panelists will lead interactive discussions on ...
(Date:9/2/2015)... ... ... Telehealth represents a growing trend among Blue Cross and Blue Shield plans, ... than 12 Blues plan clients. The September 2015 issue of The AIS ... interviewing executives at Capital Blue Cross, whose telehealth services will launch next year. Published ...
Breaking Medicine News(10 mins):Health News:James Earl Jones Hosts a New "Voices In America" Piece on Making the Workplace Healthier 2Health News:New “Extreme Weight Loss” Video Blog from the CU Anschutz Health and Wellness Center: Kim Begins with the End in Mind and Designs a Fashionable Future 2Health News:New “Extreme Weight Loss” Video Blog from the CU Anschutz Health and Wellness Center: Kim Begins with the End in Mind and Designs a Fashionable Future 3Health News:Dr. Sara Bleich, Garrison Forest Graduate, Selected for 2015-16 Class of White House Fellows 2Health News:MOAA and WWP host 2015 Warrior-Family Symposium Chairman of the Senate Committee on Veterans' Affairs and the Secretary of Veterans Affairs to Speak 2Health News:MOAA and WWP host 2015 Warrior-Family Symposium Chairman of the Senate Committee on Veterans' Affairs and the Secretary of Veterans Affairs to Speak 3Health News:AIS Newsletter Focuses on Growing Telehealth Trend Among Blues Plans 2Health News:AIS Newsletter Focuses on Growing Telehealth Trend Among Blues Plans 3
... that all villages affected by chikungunya fever would get ... among people even as 17,000 suspected cases of ... ,'We have asked the nine chikungunya-affected states to ... Health Mission, we will provide Rs.10,000 each to these ...
... apart from being heavy, overweight children share something else in ... children in Edmonton has revealed that each one of them ... intestinal cholesterol. ,The children presented high levels of ... high in overweight adults, remained in the normal range. ...
... Navarro, a researcher at the School of Pharmacy at the ... and liver cancer. The new treatment has shown promise ... ,This discovery is the principal result of her doctoral dissertation, ... Cells of the Colon, which was subsidized by the Basque ...
... Women who suffer bouts of nausea and vomiting during their ... it but it seems that going through morning sickness is ... boffins who have conducted a new study and found that ... lower risk of developing breast cancer later in life than ...
... New York Citys smoking rate has shown a decline, thanks ... the habit. The statistics in the 2006 report shows ... to 2002 figures. ,Over the past year, smoking decreased ... 20.2% to 17.1%). These large declines followed a year-long ad ...
... cause effects ranging from learning and memory capabilities to ... of St.Jude Childrens Research hospital . ... factora molecule that binds to a section of DNA near ... protein for which it codes. CREB activates genes in response ...
Cached Medicine News:Health News:Chikungunya-hit Villages to Get Funds to Fight Mosquitoes 2Health News:Researchers Identify New Risk Marker for Obese Children 2Health News:Novel Treatment Beneficial for Colon and Liver Cancer 2Health News:Morning Sickness may Signify Lower Breast Cancer Risk 2Health News:Morning Sickness may Signify Lower Breast Cancer Risk 3Health News:New York Records Decline in Smoking Rate 2Health News:Research Studies on Molecular Switches of Gene 2
... system is a family of plates that ... for consistent, reliable fixation of plate to ... backout. This innovative design eliminates the need ... your screws and the swivel ring automatically ...
Investigational use spacer with Cantilever Transforminal Lumbar Interbody Fusion and instrumentation. For Investigational use only. 7 mm height....
The CRW system is the premier stereotactic system. The CRW system can be configured as a basic CT-only system, a CT/MR scanner-dependent system, or a high-level CT/MR scanner-independent system with ...
The unique MR-frame and its indicators are made of a highly tensile and fibre reenforced Epoxyd material....
Medicine Products: